Zeria Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	24,154	23,592	20,323	16,219	11,704	9,793
Short-Term Investments	-	-	-	-	-	3
Cash & Short-Term Investments	24,154	23,592	20,323	16,219	11,704	9,796
Cash Growth	-1.48%	16.09%	25.30%	38.58%	19.48%	8.78%
Receivables	29,148	26,611	21,080	17,419	16,153	13,497
Inventory	20,943	16,433	14,489	12,764	11,950	11,104
Other Current Assets	3,281	2,893	1,917	1,801	1,856	2,916
Total Current Assets	77,526	69,529	57,809	48,203	41,663	37,313
Property, Plant & Equipment	27,033	26,641	26,517	24,591	23,139	23,634
Long-Term Investments	22,820	22,541	22,957	20,172	18,165	18,775
Goodwill	3,146	3,621	4,262	5,299	5,830	6,429
Other Intangible Assets	35,697	36,740	38,877	36,631	35,376	35,640
Long-Term Deferred Tax Assets	-	97	110	136	108	67
Other Long-Term Assets	3	2	1	2	1	1
Total Assets	166,225	159,171	150,533	135,034	124,282	121,859
Accounts Payable	5,180	3,971	3,273	1,996	2,049	1,693
Accrued Expenses	994	1,623	1,584	1,554	1,530	1,268
Short-Term Debt	36,532	34,298	38,283	34,890	33,842	44,158
Current Income Taxes Payable	4,868	3,773	1,967	749	458	562
Other Current Liabilities	10,529	10,784	9,411	7,969	6,314	6,076
Total Current Liabilities	58,103	54,449	54,518	47,158	44,193	53,757
Long-Term Debt	4,366	6,865	7,943	14,541	18,385	5,819
Pension & Post-Retirement Benefits	283	224	458	234	1,073	1,308
Long-Term Deferred Tax Liabilities	-	6,496	6,447	5,190	3,905	3,356
Other Long-Term Liabilities	7,299	1,341	1,339	2,232	1,635	1,441
Total Liabilities	70,051	69,375	70,705	69,355	69,191	65,681
Common Stock	6,593	6,593	6,593	6,593	6,593	6,593
Additional Paid-In Capital	7,641	11,685	11,685	11,685	11,685	11,685
Retained Earnings	70,645	67,207	59,254	53,462	48,860	46,380
Treasury Stock	-14,225	-18,266	-18,265	-18,264	-17,593	-14,997
Comprehensive Income & Other	25,359	22,320	20,355	11,973	5,349	6,350
Total Common Equity	96,013	89,539	79,622	65,449	54,894	56,011
Minority Interest	161	257	206	230	197	167
Shareholders' Equity	96,174	89,796	79,828	65,679	55,091	56,178
Total Liabilities & Equity	166,225	159,171	150,533	135,034	124,282	121,859
Total Debt	40,898	41,163	46,226	49,431	52,227	49,977
Net Cash (Debt)	-16,744	-17,571	-25,903	-33,212	-40,523	-40,181
Net Cash Per Share	-379.86	-398.62	-587.64	-751.86	-897.74	-872.14
Filing Date Shares Outstanding	44.08	44.08	44.08	44.08	44.21	45.36
Total Common Shares Outstanding	44.08	44.08	44.08	44.08	44.41	45.7
Working Capital	19,423	15,080	3,291	1,045	-2,530	-16,444
Book Value Per Share	2178.18	2031.31	1806.31	1484.77	1236.08	1225.66
Tangible Book Value	57,170	49,178	36,483	23,519	13,688	13,942
Tangible Book Value Per Share	1296.98	1115.67	827.66	533.55	308.22	305.09

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.